Palvella Therapeutics (PVLA) Shares Outstanding (2013 - 2026)

Palvella Therapeutics (PVLA) has 12 years of Shares Outstanding (Entity) data on file, last reported at $2.2 million in Q4 2024.

• On a quarterly basis, Shares Outstanding (Entity) rose 79.99% year-over-year to $2.2 million in Q4 2024; TTM through Dec 2024 was $2.2 million, a 79.99% increase from a year earlier, with the FY2024 full-year figure at $2.2 million, up 79.99% from the prior year.
• Shares Outstanding (Entity) for Q4 2024 stood at $2.2 million, up from $1.3 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for PVLA reached as high as $2.2 million in Q4 2024 and fell as low as $654989.0 in Q2 2020.
• Historically, Shares Outstanding (Entity) has averaged $1.0 million across 5 years, with a median of $930078.0 in 2022.
• Across the five-year window, Shares Outstanding (Entity) climbed 1.43% in 2020 and soared 79.99% in 2024, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $700035.0 in 2020, then advanced by 28.96% to $902783.0 in 2021, then rose by 3.18% to $931489.0 in 2022, then soared by 32.76% to $1.2 million in 2023, then jumped by 79.99% to $2.2 million in 2024.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $2.2 million in Q4 2024, $1.3 million in Q3 2024, and $1.3 million in Q2 2024.